TORONTO, ON and GLIL YAM, Israel, Feb. 8, 2022 /PRNewswire/ — IM Cannabis Corp. (NASDAQ: IMCC) (CSE: IMCC) (“IM Cannabis” or the “Company”), a leading medical and adult-use recreational cannabis company with operations in Israel, Canada, and Germany, has engaged international investor relations specialists MZ Group (“MZ”) to lead the Company’s strategic investor relations and financial communications program across all key markets.
MZ will work closely with IM Cannabis management to develop and implement a comprehensive capital markets strategy designed to increase the Company’s visibility throughout the investment community. The campaign will highlight IM Cannabis’ position at the forefront of the global cannabis industry and the Company’s progress with its expansion strategy through regulatory and supply chain expertise, synergistic multi-market benefits, global consumer insights, and advancements in medical cannabis. MZ maintains offices worldwide and has developed a distinguished reputation as a premier resource for institutional investors, brokers, analysts, and private investors.
Brooks Hamilton, Director at MZ North America, will advise IM Cannabis in all facets of corporate and financial communications, including the coordination of non-deal roadshows and investment conferences across key cities and building brand awareness with financial and social media outlets.
Brooks Hamilton commented: “IM Cannabis has built a diversified portfolio of brands to supply premium, forward-looking product offerings to consumers on a global scale, supported by high quality cultivation and a robust distribution platform. As a multi-country operator with a footprint in the three largest federally legal markets, the Company is uniquely positioned to capitalize on evolving industry and consumer trends within the medical cannabis and adult-use recreational markets, and to capture further international market share.”
We are working to maximize the potential of our global supply chain, as well as achieve continued market-share growth of our popular brands in Canada, broaden our sales channels in Israel, and prepare for our entrance to the European market.
Oren Shuster, Chief Executive Officer of IM Cannabis
We look forward to working with Brooks and the entire team at MZ Group to effectively communicate our strategy for sustainable, long-term value creation for our shareholders.
For more information on IM Cannabis, please visit the Company’s website at www.imcannabis.com. To schedule a conference call with management, please email your request to IMCC@mzgroup.us or call Brooks Hamilton at +1 949-546-6326.
The investor relations agreement between the Company and MZ (the “Agreement”) commenced on February 1, 2022 for a term of three months until April 30, 2022, and will automatically renew for an indefinite period, subject to termination by either party upon 30 days prior written notice. Pursuant to the Agreement, MZ Group will be paid a fee of USD $14,000 per month, plus applicable taxes. Subject to the terms of the Agreement and if the Agreement remains in effect as of August 1, 2022, the Company will issue MZ 35,000 common shares at a price per share to be determined on the market price of the Company’s common shares on the Canadian Securities Exchange (“CSE”) on the trading day prior to August 1, 2022, subject to applicable discounts permitted under CSE policies.
About IM Cannabis Corp.
IM Cannabis (NASDAQ: IMCC) (CSE: IMCC) is a leading international cannabis company providing premium products to medical patients and adult-use recreational consumers. IM Cannabis is one of the very few companies with operations in Israel, Germany, and Canada, the three largest federally legal markets. The ecosystem created through its international operations leverages the Company’s unique data-driven perspective and product supply chain globally. With its commitment to responsible growth and financial prudence, and the ability to operate within the strictest regulatory environments, the Company has quickly become one of the leading cultivators and distributors of high-quality cannabis globally.
The IM Cannabis ecosystem operates in Israel through its commercial relationship with Focus Medical Herbs Ltd. (“Focus Medical”), which cultivates, imports, and distributes cannabis to medical patients, leveraging years of proprietary data and patient insights. The Company also operates medical cannabis retail pharmacies, online platforms, distribution centres and logistical hubs in Israel that enable the safe delivery and quality control of IM Cannabis products throughout the entire value chain. In Germany, the IM Cannabis ecosystem operates through Adjupharm GmbH (“Adjupharm”), where it also distributes cannabis to pharmacies to medical cannabis patients. In Canada, IM Cannabis operates through Trichome Financial Corp. (“Trichome”) and its subsidiaries Trichome JWC Acquisition Corp. (“TJAC”) and MYM Nutraceuticals Inc. (“MYM”), where it cultivates and processes cannabis for the adult-use market at its Ontario, Nova Scotia, and Quebec facilities under the WAGNERS and Highland Grow brands. For more information, please visit www.imcannabis.com.
About MZ Group
MZ North America is the US division of MZ Group, a global investor relations and corporate communications leader. MZ North America was founded in 1996 and provides full scale Investor Relations to both private and public companies across all industries. Supported by an exclusive one-stop-shop approach, MZ works with top management to support its clients’ business strategies via integrated product and service categories: 1) IR Consulting & Outreach – full service investor relations and roadshow services; 2) IPO Advisory & SPAC IR – preparation for the Pre-IPO journey and leading sponsor/target companies through the SPAC business combination; 3) Public Relations – targeted campaigns and broad media outreach; 4) ESG iQ & Advisory – reporting technology platform and ESG guidance; 5) Market Intelligence – real time ownership monitoring; 6) Technology Solutions – websites, webcasting, conference calls, distribution services and board portals. MZ has a global footprint with offices located in New York, Chicago, San Diego, Aliso Viejo, Austin, Minneapolis, Taipei and São Paulo. For more information, please visit www.mzgroup.us.